Nadezhda N. Zvereva

Nadezhda N. Zvereva

Auto-generated profile, based on publicly available information

Nadezhda N. Zvereva

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
MBMaya D. Bakradze
Maya D. Bakradze
ABAlexander A. Baranov
Alexander A. Baranov
TBTatiana T. Batysheva
Tatiana T. Batysheva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

10 June 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EBElena N. Baybarina
Elena N. Baybarina
ABAlexander A. Baranov
Alexander A. Baranov
EVElena A. Vishneva
Elena A. Vishneva
NZNadezda N. Zvereva
Nadezda N. Zvereva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has developed guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

13 April 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
NZN.N. Zvereva
N.N. Zvereva
MSM.A. Sayfullin
M.A. Sayfullin
ARA.Yu. Rtishchev
A.Yu. Rtishchev
OSO.V. Shamsheva
O.V. Shamsheva
NPNatalia Pshenichnaya
Natalia Pshenichnaya
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

1 January 2017 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
NZN. N. Zvereva
N. N. Zvereva
KSK. Shakaryan
K. Shakaryan
RSR. F. Sayfullin
R. F. Sayfullin
AРArray Л. Россина
Array Л. Россина
YRYu. Rtishchev
Yu. Rtishchev
AБArray Х. Белялетдинова
Array Х. Белялетдинова
СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ ИКСОДОВОГО КЛЕЩЕВОГО БОРРЕЛИОЗА (БОЛЕЗНИ ЛАЙМА) У ДЕТЕЙ

1 October 2021 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
RSRuslan Faridovich Sayfullin
Ruslan Faridovich Sayfullin
NPNadezhda E. Perekopskaya
Nadezhda E. Perekopskaya
LKLudmila S. Karan
Ludmila S. Karan
NZNadezhda N. Zvereva
Nadezhda N. Zvereva
MSMuhammad A. Sayfullin
Muhammad A. Sayfullin
We describe an autochthonous case of Rickettsia slovaca infection in a man 35 years of age from Russia who had tickborne lymphadenopathy. We used ELISA and quantitative PCR testing to further identify DNA and confirm diagnosis. Physicians in Russia should consider similar diseases in differential diagnoses after tick bites.

16 November 2022 in Problems of Virology
Verified
Journal Article
Open access
PDF file
MSMukhammad A. Sayfullin
Mukhammad A. Sayfullin
NZNadezda N. Zvereva
Nadezda N. Zvereva
LKLuidmila S. Karan
Luidmila S. Karan
YGYana E. Grigoreva
Yana E. Grigoreva
YAYulia A. Akinshina
Yulia A. Akinshina
SSSvetlana V. Smetanina
Svetlana V. Smetanina
Introduction. In Russia, the approved morbidity statistics system is represented by the International Classification of Diseases of the 10th revision (ICD-10). This classification provides two forms of dengue fever (DF): dengue fever (A90) and hemorrhagic dengue (A91). Official statistics on the ratio of forms of DF is not published in open sources and this lack of information about the real ratio of the forms of DF makes it difficult to objectively assess the factors that determine the severity of this disease. The aim: compare the clinical and epidemiological features of dengue fever and hemorrhagic dengue fever in patients hospitalized in 20092019 to the City Infectious Clinical Hospital No. 1, Moscow. Materials and methods. A retrospective cohort study. We analyzed the patient database and reviewed 391 medical records of patients with diagnosed dengue fever. We compared gender, age characteristics, travel geography including information about previous visits of patients to endemic regions and dengue virus serotype. To determine the primary and re-infection rate, an analysis of IgG for the dengue virus was carried out on days 15 of the disease. To compare indicators, 95% confidence intervals for proportions, medians, and interquartile ranges were calculated. The significance of differences between independent samples for assessing qualitative characteristics was carried out using the criteria 2, the odds ratio. To assess the quantitative characteristics, the Mann-Whitney test was used. Differences were considered statistically significant at p 0.05. Results. The proportion of patients with dengue fever was 14.9% of all hospitalized with febrile illnesses that developed after international travel. Hemorrhagic dengue fever (DHF) was diagnosed in 15.7% of patients with dengue fever. DHF developed significantly more often in women, as well as in those who had history of repeated visits to endemic regions. However, DHF was also diagnosed in 10.9% of first-time travelers to tropical countries. We did not find significant differences in the rates of DHF development depending on age and dengue virus serotype. In a number of patients who had not previously traveled to endemic regions, IgG to the dengue virus were detected, which may indicate a previous infection with related flaviviruses. Conclusion. It has been established that in the regions most visited by Russians, there is a circulation of all serotypes of the dengue virus with an annual change in the predominant serotype.